Literature DB >> 11835981

A sexual arousability model involving steroid effects at the plasma membrane.

Jack D Caldwell1.   

Abstract

This review will discuss the status of research related to sexual arousability. It will also present a model for sexual arousability based on current knowledge of steroids effects at the membranes of cells. Steroids have multiple rapid actions that are suggested to result from actions at membrane-associated receptors. When stimulated by steroids these receptors alter G-protein coupling in a manner unique to this complex. Initial stimulation of the receptors by steroids alters the coupling pattern of G-proteins and of other binding sites associated with the complex. This change in G-protein coupling is a stable alteration and thus may serve as a long-term change in the system, which is a requirement of sexual arousability. Stimulation of this receptor system by a surge of oxytocin at ejaculation or orgasm then decouples the G-protein and reduces arousability. Sex hormone binding globulin may be an important ligand at this complex. This model suggests completely new relationships among steroids and their receptors that may complement or diverge from actions at known intracellular receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835981     DOI: 10.1016/s0149-7634(01)00035-5

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  5 in total

1.  Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming.

Authors:  Carolyn J Koonce; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

2.  Membrane progestin receptors in the midbrain ventral tegmental area are required for progesterone-facilitated lordosis of rats.

Authors:  Cheryl A Frye; Alicia A Walf; Amy S Kohtz; Yong Zhu
Journal:  Horm Behav       Date:  2013-06-12       Impact factor: 3.587

3.  The roles of testosterone and alpha-amylase in exercise-induced sexual arousal in women.

Authors:  Lisa Dawn Hamilton; Emily A Fogle; Cindy M Meston
Journal:  J Sex Med       Date:  2008-01-21       Impact factor: 3.802

4.  Chronic stress and sexual function in women.

Authors:  Lisa Dawn Hamilton; Cindy M Meston
Journal:  J Sex Med       Date:  2013-07-10       Impact factor: 3.802

Review 5.  Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.

Authors:  Sandra Léa Bonfim Reis; Carmita H N Abdo
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.